
Sign up to save your podcasts
Or
Show Notes:
In this episode of the SMFM podcast, Dr. Marwan Maayeh is joined by Dr. Sura Alwan, an expert in teratology and birth defects epidemiology. Together, they explore the role of teratogens—agents that can cause birth abnormalities when exposed to the developing fetus. The conversation covers a wide range of topics, including the challenges MFM specialists face when counseling patients on medication use during pregnancy and the resources available for healthcare professionals and patients alike. Dr. Alwan highlights the work of OTIS (Organization of Teratology Information Specialists) and TERIS (Teratogen Information System) in providing evidence-based guidance on drug and environmental exposures in pregnancy. They also discuss the importance of research in identifying and managing teratogenic risks, the role of teratology databases, and combating misinformation in the field. Tune in for practical insights and resources on navigating these complex issues in MFM practice.
Additional Resources:
TERIS
OTIS/MotherToBaby
Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication Practice Guideline From the AAN, AES, and SMFM
smfmadvocates.org/positions
Transcript: Click here for the full transcript
4.7
2424 ratings
Show Notes:
In this episode of the SMFM podcast, Dr. Marwan Maayeh is joined by Dr. Sura Alwan, an expert in teratology and birth defects epidemiology. Together, they explore the role of teratogens—agents that can cause birth abnormalities when exposed to the developing fetus. The conversation covers a wide range of topics, including the challenges MFM specialists face when counseling patients on medication use during pregnancy and the resources available for healthcare professionals and patients alike. Dr. Alwan highlights the work of OTIS (Organization of Teratology Information Specialists) and TERIS (Teratogen Information System) in providing evidence-based guidance on drug and environmental exposures in pregnancy. They also discuss the importance of research in identifying and managing teratogenic risks, the role of teratology databases, and combating misinformation in the field. Tune in for practical insights and resources on navigating these complex issues in MFM practice.
Additional Resources:
TERIS
OTIS/MotherToBaby
Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication Practice Guideline From the AAN, AES, and SMFM
smfmadvocates.org/positions
Transcript: Click here for the full transcript
60 Listeners
7,700 Listeners
493 Listeners
43,442 Listeners
3,332 Listeners
420 Listeners
549 Listeners
14,393 Listeners
8,209 Listeners
203 Listeners
57,990 Listeners
28,304 Listeners
41,337 Listeners
20,416 Listeners
7,290 Listeners